文献速递血栓与止血

酪氨酸激酶Chk与Csk及磷酸酶PTPRJ相互作用调控小鼠血小板

Interplay between the tyrosine kinases Chk and Csk and phosphatase PTPRJ is critical for regulating platelets in mice.
PubMed 文献 · Blood · 2020-01-01

本研究在小鼠中探究Chk在血小板中的作用及其与Csk的功能冗余,并分析Chk、Csk和PTPRJ三基因联合敲除的生理后果。Chk敲除小鼠血小板计数正常,Chk;Csk双敲除小鼠血小板减少92%,Chk;Csk;Ptprj三敲除小鼠血小板减少部分恢复。研究表明SFKs抑制性磷酸化降低导致血小板减少,Csk是血小板中主要抑制因子,Chk起辅助作用,靶向PTPRJ可能具有治疗益处。

要点

  • Chk;Csk双敲除小鼠血小板减少92%,三敲除后部分恢复。
  • 双敲除和三敲除小鼠巨核细胞数量均显著增加。
  • Csk是血小板中SFKs的主要抑制因子,Chk起辅助作用。

核心结论

  • SFKs抑制性磷酸化降低导致血小板减少,Csk是血小板中主要抑制因子,Chk起辅助作用。
  • 在Chk和Csk缺失基础上再敲除PTPRJ可减轻血小板减少程度,提示靶向PTPRJ可能具有治疗益处。

研究设计与样本

  • 研究采用Chk敲除、Chk;Csk双敲除和Chk;Csk;Ptprj三敲除小鼠模型。

主要发现

  • Chk敲除小鼠血小板计数正常。
  • Chk;Csk双敲除小鼠血小板计数减少92%。
  • Chk;Csk;Ptprj三敲除小鼠血小板减少部分恢复。
  • 双敲除和三敲除小鼠巨核细胞数量均显著增加。
  • 双敲除血小板中SFKs抑制性酪氨酸磷酸化几乎完全消失,三敲除血小板中Src和Fyn的该磷酸化部分恢复。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The Src family kinases (SFKs) Src, Lyn, and Fyn are essential for platelet activation and also involved in megakaryocyte (MK) development and platelet production. Platelet SFKs are inhibited by C-terminal Src kinase (Csk), which phosphorylates a conserved tyrosine in their C-terminal tail, and are activated by the receptor-type tyrosine phosphatase PTPRJ (CD148, DEP-1), which dephosphorylates the same residue. Deletion of Csk and PTPRJ in the MK lineage in mice results in increased SFK activity, but paradoxically hypoactive platelets resulting from negative feedback mechanisms, including upregulation of Csk homologous kinase (Chk) expression. Here, we investigate the role of Chk in platelets, functional redundancy with Csk, and the physiological consequences of ablating Chk, Csk, and PTPRJ in mice. Platelet count was normal in Chk knockout (KO) mice, reduced by 92% in Chk;Csk double KO (DKO) mice, and partially rescued in Chk;Csk;Ptprj triple KO (TKO) mice. Megakaryocyte numbers were significantly increased in both DKO and TKO mice. Phosphorylation of the inhibitory tyrosine of SFKs was almost completely abolished in DKO platelets, which was partially rescued in Src and Fyn in TKO platelets. This residual phosphorylation was abolished by Src inhibitors, revealing an unexpected mechanism in which SFKs autoinhibit their activity by phosphorylating their C-terminal tyrosine residues. We demonstrate that reduced inhibitory phosphorylation of SFKs leads to thrombocytopenia, with Csk being the dominant inhibitor in platelets and Chk having an auxiliary role. PTPRJ deletion in addition to Chk and Csk ameliorates the extent of thrombocytopenia, suggesting targeting it may have therapeutic benefits in such conditions.

来源:Blood,查看原文。版权归原作者所有。

引用

  1. Nagy Z, Mori J, Ivanova VS, et al. Interplay between the tyrosine kinases Chk and Csk and phosphatase PTPRJ is critical for regulating platelets in mice. Blood. 2020. PMID: 32016283. doi:10.1182/blood.2019002848

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。